Form 4: Cencora Executive Chairman Steven H. Collis Reports Share Transactions
SEC Form 4 Filing
Executive Chairman of Cencora, Steven H. Collis, reports acquisition of shares and disposition for tax obligations.
Summary
- Steven H. Collis, Executive Chairman of Cencora, reported acquiring 123,528 shares of common stock on November 21, 2024, at no cost due to the vesting of performance share units.
- He also disposed of 53,723 shares on the same day at a price of $225.08 per share to cover tax obligations related to the vesting.
- Following these transactions, Mr. Collis directly owns 376,556.665 shares of Cencora common stock.
- Additionally, Mr. Collis was granted 9,869 restricted stock units on November 20, 2024, which will vest in three equal installments over the next three years.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative developments. The sentiment is neutral to slightly positive due to the vesting of performance-based awards.
Positives
- The acquisition of 123,528 shares at no cost indicates the achievement of performance targets.
- The grant of 9,869 restricted stock units further aligns the executive's interests with the company's long-term performance.
Negatives
- The sale of 53,723 shares, while for tax purposes, reduces the total number of shares directly held by Mr. Collis.
Risks
- The sale of shares, even for tax purposes, could be interpreted negatively by some investors.
Future Outlook
The restricted stock units will vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027.
Industry Context
This is a routine filing related to executive compensation and does not indicate any significant change in the company's operations or outlook.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards, similar to the performance share units and restricted stock units granted to Mr. Collis.
- Tax-related sales of shares are a common occurrence when equity awards vest, and this transaction is consistent with standard practice.
- Companies like McKesson and Cardinal Health also use similar equity-based compensation for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation practices.
- The vesting of performance share units indicates that the company has met certain performance targets, which is positive for shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/20/2024 | Grant date of 9,869 restricted stock units. |
| 11/21/2024 | Acquisition of 123,528 shares and disposition of 53,723 shares. |
| 11/20/2025 | First vesting date for restricted stock units. |
| 11/20/2026 | Second vesting date for restricted stock units. |
| 11/20/2027 | Third vesting date for restricted stock units. |
| 11/22/2024 | Date of filing of the Form 4. |
Keywords
Cencora, Steven H. Collis, share transactions, Form 4, executive chairman, restricted stock units, performance share units, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.